Cargando…

Tracking dyspnea up to supplemental oxygen prescription among patients with pulmonary fibrosis

BACKGROUND: Dyspnea is the hallmark symptom of pulmonary fibrosis. Supplemental oxygen (O(2)) is prescribed to many patients with pulmonary fibrosis in hopes of alleviating dyspnea and improving physical functioning. We used response data from the University of California San Diego Shortness of Brea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olson, Amy L., Graney, Bridget, Baird, Susan, Churney, Tara, Fier, Kaitlin, Korn, Marjorie, McCormick, Mark, Sprunger, David, Vierzba, Thomas, Wamboldt, Frederick S., Swigris, Jeffrey J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700736/ https://www.ncbi.nlm.nih.gov/pubmed/29166901 http://dx.doi.org/10.1186/s12890-017-0497-0

Ejemplares similares

Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
por: Graney, Bridget A., et al.
Publicado: (2017)

Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen
por: Root, Elisabeth Dowling, et al.
Publicado: (2017)

Protocol for a mixed-methods study of supplemental oxygen in pulmonary fibrosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Seeking and sharing: why the pulmonary fibrosis community engages the web 2.0 environment
por: Albright, Karen, et al.
Publicado: (2016)

Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users
por: Cao, Mengshu, et al.
Publicado: (2015)

Understanding the informational needs of patients with IPF and their caregivers: ‘You get diagnosed, and you ask this question right away, what does this mean?’
por: Ramadurai, Deepa, et al.
Publicado: (2018)

Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers
por: Ramadurai, Deepa, et al.
Publicado: (2019)

Development of ATAQ-LAM: a tool to assess quality of life in Lymphangioleiomyomatosis
por: Walker, Tarik D., et al.
Publicado: (2015)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

“Getting stuck with LAM”: patients perspectives on living with Lymphangioleiomyomatosis
por: Belkin, Amanda, et al.
Publicado: (2014)

Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire
por: Swigris, Jeffrey J., et al.
Publicado: (2020)

A 62-year-old man with dyspnea
por: Baqir, Misbah, et al.
Publicado: (2016)

ADEPT - Abnormal Doppler Enteral Prescription Trial
por: Leaf, Alison, et al.
Publicado: (2009)

Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives
por: Graney, Bridget A, et al.
Publicado: (2018)

Prenatal and Cardiovascular Outcome in Pregnant Patients With Dyspnea
por: Tara, Fateme, et al.
Publicado: (2015)

Prescription Tracking and Public Health
por: Fugh-Berman, Adriane
Publicado: (2008)

Dyspnea: an update
por: Scano, Giorgio
Publicado: (2010)

Man with dyspnea
por: Favot, Mark, et al.
Publicado: (2020)

Woman with dyspnea
por: Harris, Jordan, et al.
Publicado: (2020)

Woman With Dyspnea
por: Tagan, Damien
Publicado: (2023)

A woman with dyspnea and recurrent pneumothorax: when dyspnea is not asthma
por: Chidharla, Anusha, et al.
Publicado: (2020)

The Barthel index-dyspnea: a new two-dimensional dyspnea scale
por: Chuang, Ming-Lung
Publicado: (2016)

Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
por: Fernández Pérez, Evans R., et al.
Publicado: (2021)

Mr. Lipscomb, on Dyspnea
por: Lipscomb, G.
Publicado: (1800)

Woman with dyspnea and hypoxia
por: Griesmer, Katherine B., et al.
Publicado: (2023)

Dalhousie dyspnea scales: construct and content validity of pictorial scales for measuring dyspnea
por: McGrath, Patrick J, et al.
Publicado: (2005)

Differentiating Cardiac and Pulmonary Causes of Dyspnea Using Ultrasonography and Dyspnea Discrimination Index
por: Chandy, Gina M, et al.
Publicado: (2022)

The Reliability of the Arabic Version of the Dyspnea Index Questionnaire for Upper Airway-Related Dyspnea
por: Alrabiah, Abdulaziz, et al.
Publicado: (2022)

The emotion storyboard: A method to examine social judgments of emotion
por: McCormick-Huhn, Kaitlin, et al.
Publicado: (2021)

Favorable Evaluations of Black and White Women’s Workplace Anger During the Era of #MeToo
por: McCormick-Huhn, Kaitlin, et al.
Publicado: (2021)

The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension
por: Banerjee, Debasree, et al.
Publicado: (2017)

Time course of dyspnea evolution in the emergency department: results from the URGENT dyspnea survey
por: Tavares, M, et al.
Publicado: (2009)

Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study
por: Figarska, Sylwia M., et al.
Publicado: (2012)

Is the Fundamental Electrical Response of the Single Heart Muscle Cell a Spike Potential?
por: Churney, Leon, et al.
Publicado: (1963)

Consumer Understanding and Satisfaction Associated With a 3-Tier Prescription Drug Benefit
por: Olson, Bridget M., et al.
Publicado: (2005)

Cigarette Smoking and Dyspnea Perception
por: Rosi, Elisabetta, et al.
Publicado: (2004)

Cigarette Smoking and Dyspnea Perception
por: Rosi, Elisabetta, et al.
Publicado: (2004)

Ultrasound diagnosis of an acute dyspnea
por: Lichtenstein, D, et al.
Publicado: (2003)

Mechanisms of dyspnea in healthy subjects
por: Gigliotti, Francesco
Publicado: (2010)

Measures of dyspnea in pulmonary rehabilitation
por: Crisafulli, Ernesto, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tetesaghhotlecvc7d14knti0f